Officer Jesse J. Geiger Files Intent to Sell $14.5M in Medpace Holdings Stock
MEDP sits 81% above its 52-week low of $250.05 on light trading volume (0.4× avg).
Summary
Medpace Holdings officer Jesse J. Geiger has filed a Form 144 indicating an intent to sell 31,707 shares of common stock, valued at approximately $14.5 million.
Key Events · Ownership and Investor Activity · MEDP
-
Officer Files Intent to Sell Shares
Jesse J. Geiger, an officer of Medpace Holdings, Inc., filed a Form 144 indicating an intent to sell 31,707 shares of common stock.
-
Significant Value of Proposed Sale
The shares intended for sale are valued at approximately $14.5 million, representing a notable disposition by an insider.
-
Shares Acquired via Option Grant
The shares to be sold were acquired through an option grant on February 15, 2022, and are intended for sale on or after March 17, 2026.
Analysis · MEDP · Industrial Applications And Services
This Form 144 filing signals an upcoming significant disposition of shares by a company officer. The proposed sale of over $14.5 million worth of stock by Jesse J. Geiger, acquired through option grants, represents a notable insider selling event. While the company recently reported strong financial results and a share repurchase program, this intent to sell by an officer could be interpreted by investors as a move to monetize holdings, potentially adding to market overhang.
At the time of this filing, MEDP was trading at $452.27 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $12.8B. The 52-week trading range was $250.05 to $628.92. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.